RDGT
Ridgetech, Inc.
NASDAQ: RDGT · HEALTHCARE · PHARMACEUTICAL RETAILERS
$1.42
-7.22% today
Updated 2026-06-03
Market cap
$1.27M
P/E ratio
—
P/S ratio
0.01x
EPS (TTM)
$-54.61
Dividend yield
—
52W range
$1 – $761
Volume
56.8M
WallStSmart proprietary scores
37
out of 100
Grade: D
Sell
Investment rating
2.7
Growth
F6.5
Quality
B5.0
Profitability
C+5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
1.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ ROE 30.21% — strong efficiency
+ Free cash flow $5.35M — positive
+ Debt/equity 0.16x — low leverage
Risks
- Altman Z 1.41 — distress zone
- Revenue declining -11.70% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $164.39M | $148.81M | $154.54M | $119.97M | $119.94M |
| Net income | $-3.19M | $-21.14M | $-4.23M | $10.19M | $-60167.00 |
| EPS | — | — | — | — | $-54.61 |
| Free cash flow | $-5.69M | $-3.60M | $-4.08M | $632503.00 | $5.35M |
| Profit margin | -1.94% | -14.20% | -2.74% | 8.50% | 10.30% |
Peer comparison
Smart narrative
Ridgetech, Inc. trades at $1.42. Our Smart Value Score of 37/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.41, it sits in the distress. TTM revenue stands at $119.94M. with profit margins at 10.30%.
Frequently asked questions
What is Ridgetech, Inc.'s stock price?
Ridgetech, Inc. (RDGT) trades at $1.42, on a P/S of 0.0x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Ridgetech, Inc. overvalued?
Ridgetech, Inc. carries a Smart Value Score of 37/100 (Grade D), which we rate Sell. That score blends growth, quality, and valuation into one read.
What is Ridgetech, Inc.'s revenue?
Ridgetech, Inc.'s trailing twelve-month revenue is $119.94M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Ridgetech, Inc.'s Altman Z-Score is 1.41, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryPHARMACEUTICAL RETAILERS
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.01x
ROE30.21%
Beta-0.21
50D MA$2.99
200D MA$252.59
Shares out0.00B
Float0.00B
Short ratio—
Avg volume56.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—